You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 13, 2024

CLINICAL TRIALS PROFILE FOR GABAPENTIN ENACARBIL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for GABAPENTIN ENACARBIL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00311363 ↗	Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.	Completed	XenoPort, Inc.	Phase 3	2006-04-01	The primary objective of this trial is to assess the maintenance of efficacy of gabapentin enacarbil (GEn, XP13512) taken once daily in the long-term treatment of patients suffering from Restless Legs Syndrome (RLS).
NCT00333359 ↗	XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.	Completed	XenoPort, Inc.	Phase 3	2006-06-01	The primary objective of this trial is to assess the long-term safety and efficacy of XP13512 (Gabapentin Enacarbil) taken once daily for the treatment of patients suffering from Restless Legs Syndrome (RLS).
NCT00365352 ↗	XP13512 vs. Placebo in Patients With Restless Legs Syndrome.	Completed	XenoPort, Inc.	Phase 3	2006-08-01	The primary objective of this trial is to assess the efficacy of XP13512 taken once daily compared to placebo for the treatment of patients suffering from Restless Legs Syndrome (RLS).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for GABAPENTIN ENACARBIL

Condition Name

Chart
Table

Condition Name for GABAPENTIN ENACARBIL
Intervention	Trials
Restless Legs Syndrome	12
Restless Legs Syndrome (RLS)	4
RLS	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for GABAPENTIN ENACARBIL
Intervention	Trials
Restless Legs Syndrome	20
Psychomotor Agitation	13
Syndrome	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for GABAPENTIN ENACARBIL

Trials by Country

Map
Table

Trials by Country for GABAPENTIN ENACARBIL
Location	Trials
United States	157
Japan	14
Germany	7
Canada	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for GABAPENTIN ENACARBIL
Location	Trials
Texas	12
Florida	9
California	9
Ohio	8
Pennsylvania	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for GABAPENTIN ENACARBIL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for GABAPENTIN ENACARBIL
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	5
Phase 2	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for GABAPENTIN ENACARBIL
Clinical Trial Phase	Trials
Completed	23
Recruiting	3
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GABAPENTIN ENACARBIL

Sponsor Name

Chart
Table

Sponsor Name for GABAPENTIN ENACARBIL
Sponsor	Trials
XenoPort, Inc.	18
Astellas Pharma Inc	6
Arbor Pharmaceuticals, Inc.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for GABAPENTIN ENACARBIL
Sponsor	Trials
Industry	26
Other	6
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.